UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061257
Receipt number R000069331
Scientific Title Impact of open Septorhinoplasty on Obstructive Sleep Apnea and Nasal Symptoms: A Prospective Observational Study
Date of disclosure of the study information 2026/04/14
Last modified on 2026/04/14 14:58:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of Septorhinoplasty on Obstructive Sleep Apnea and Nasal Symptoms: A Prospective Observational Study

Acronym

OSRP-OSA Study

Scientific Title

Impact of open Septorhinoplasty on Obstructive Sleep Apnea and Nasal Symptoms: A Prospective Observational Study

Scientific Title:Acronym

OSRP-OSA

Region

Japan


Condition

Condition

Nasal obstruction; Obstructive sleep apnea; Deviated nasal septum

Classification by specialty

Cardiology Psychiatry Oto-rhino-laryngology
Oral surgery Plastic surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate, from both subjective and objective perspectives, the extent to which improvement in nasal airflow following OSRP contributes to changes in the severity of OSA and patient-reported nocturnal nasal obstruction symptoms. In addition, this study will exploratorily assess the potential for resumption of treatment in patients in whom nasal obstruction had interfered with the initiation or continuation of continuous positive airway pressure (CPAP) therapy. Furthermore, it aims to investigate the prevalence of undiagnosed OSA among patients undergoing OSRP primarily for nasal obstruction.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in the respiratory event index (REI) from preoperative baseline to 6 months postoperatively

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Open septorhinoplasty will be performed, and daytime sleepiness questionnaires and portable sleep apnea monitor assessments will be conducted before and after surgery.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients undergoing open septorhinoplasty (OSRP) at the Department of Plastic and Reconstructive Surgery, The Jikei University Hospital; age over 18 years; patients able to undergo both preoperative and postoperative assessments, including the Japanese version of the Standardized Cosmesis and Health Nasal Outcomes Survey (J-SCHNOS), the Japanese version of the Epworth Sleepiness Scale (JESS), and portable sleep apnea testing; patients who provide written informed consent to participate in this study

Key exclusion criteria

Patients deemed unlikely to complete follow-up through 12 months postoperatively; patients for whom study assessments are considered inappropriate due to severe comorbidities or acute illnesses; pregnant patients or those who may be pregnant; patients who are not native Japanese speakers; patients with a history of craniofacial trauma within the past 3 months

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Ato
Middle name
Last name Hamasaki

Organization

The Jikei University Hospital

Division name

Department of Plastic and Reconstructive Surgery

Zip code

105-8471

Address

3-19-18 Nishi-Shimbashi, Minato-ku, Tokyo 105-8471, Japan

TEL

03-3433-1111

Email

atohamasaki@gmail.com


Public contact

Name of contact person

1st name Ato
Middle name
Last name Hamasaki

Organization

The Jikei University Hospital

Division name

Department of Plastic and Reconstructive Surgery

Zip code

105-8471

Address

3-19-18 Nishi-Shimbashi, Minato-ku, Tokyo 105-8471, Japan

TEL

03-3433-1111

Homepage URL


Email

atohamasaki@gmail.com


Sponsor or person

Institute

The Jikei University

Institute

Department

Personal name



Funding Source

Organization

Teijin Pharma Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of The Jikei University School of Medicine

Address

3-19-18 Nishi-Shimbashi, Minato-ku, Tokyo 105-8471, Japan

Tel

03-3433-1111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 01 Day

Date of IRB

2026 Year 04 Month 13 Day

Anticipated trial start date

2026 Year 04 Month 20 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 14 Day

Last modified on

2026 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069331